Publications by authors named "Francesco Rosario Di Stefano"
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.
Giovanni Farinea Mariangela Calabrese Federica Carfì Isabella Saporita Stefano Poletto Francesco Rosario Di Stefano
Cells
August 2024
Article Synopsis
- * A study analyzed 327 mCRPC patients on Enzalutamide or Abiraterone, finding that 9.8% had NED, which was associated with significantly poorer progression-free survival (PFS), disease control rate (DCR), and PSA response.
- * The negative impact of NED on patient outcomes was consistent regardless of treatment line, suggesting that assessing NED could help in making better treatment choices for mCRPC.